サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1672101

世界のバイオプロセス技術市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Bioprocess Technology Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 110 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
世界のバイオプロセス技術市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 110 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオプロセス技術市場規模は、2024年の376億3,000万米ドルから2033年には807億8,000万米ドルに成長し、2026年から2033年の予測期間中に8.86％の堅調な年間平均成長率（CAGR）を示すと予測されます。

バイオプロセス技術市場は、バイオ医薬品の需要増と効率的な生産プロセスの必要性によって大きな成長を遂げています。バイオプロセス技術には、ワクチン、モノクローナル抗体、組換えタンパク質を含む生物学的製剤の開発・製造に使用されるさまざまな技術が含まれます。世界のバイオ医薬品産業が拡大を続ける中、生産性を向上させ、コストを削減する高度なバイオプロセス・ソリューションへの需要が高まっています。企業は、製造業務の合理化と製品の品質向上のためにバイオプロセス技術への投資を増やしており、この市場は堅調な拡大が見込まれています。

さらに、バイオプロセス技術の進歩が市場内の技術革新を促進しています。連続製造プロセス、シングルユース技術、自動化ソリューションの開発は、バイオ医薬品の製造方法を変革しつつあります。これらの技術革新は効率を高めるだけでなく、汚染リスクを低減し、拡張性を向上させます。バイオプロセス技術市場が進化を続ける中、バイオ医薬品業界の多様なニーズに対応するソリューションの幅を広げる上で、継続的な研究開発が重要な役割を果たすでしょう。

さらに、個別化医療と標的治療が重視されるようになり、バイオプロセス技術の展望が形成されつつあります。ヘルスケアプロバイダーが個々の患者に合わせた治療を求める傾向が強まるにつれ、柔軟で適応性の高いバイオプロセス・ソリューションへの需要が高まる可能性が高いです。この動向は、カスタマイズされた生物学的製剤の生産に高度なバイオプロセス技術が必要とされる細胞・遺伝子治療において特に関連性が高いです。バイオプロセス技術市場が成長を続ける中、技術の進歩、規制遵守、個別化医療の推進が融合することで、バイオ製薬企業がヘルスケア状況の進化に対応できるよう、将来の軌道を形成する上で極めて重要な役割を果たすでしょう。

当社のレポートは、様々な業界や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション

市場促進要因：市場成長に影響を与える主な促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 BIOPROCESS技術：産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 世界のバイオプロセス技術市場分析：製品別

  • 製品別概要
  • 製品別の過去および予測データ分析
  • 消耗品・アクセサリー（培地、試薬、その他）
  • 機器（バイオプロセス分析装置、血液ガス分析装置、浸透圧計、セルカウンター、インキュベーター、バイオリアクター、その他（遠心分離、スペクトロメーター、ろ過））

第6章 世界のバイオプロセス技術市場分析：用途別

  • 概要：用途別
  • 過去および予測データ分析：用途別
  • 一次外科手術
  • 抗生物質
  • 組み換えタンパク質
  • モノクローナル抗体
  • バイオシミラー

第7章 世界のバイオプロセス技術市場分析：最終用途別

  • 最終用途別概要
  • 最終用途別過去および予測データ分析
  • バイオ医薬品企業
  • 製造受託機関
  • 受託研究機関
  • 食品・飼料産業
  • 学術研究機関

第8章 世界のバイオプロセス技術市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域セグメント別
    • アジア太平洋地域国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカセグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカセグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第9章 バイオプロセス技術企業の競合情勢

  • バイオプロセス技術市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • GE Healthcare
  • Sartorius AG
  • Becton
  • Dickinson And Company
  • Danaher Corporation
  • Eppendorf AG
  • Lonza
  • Advanced Instruments
  • Nova Biomedical
  • F. Hoffmann-La Roche Ltd
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Consumables & Accessories (Culture Media, Reagents, Others) Market Sales By Geography (USD MN)
  • Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Primary Surgical Market Sales By Geography (USD MN)
  • Antibiotics Market Sales By Geography (USD MN)
  • Recombinant Proteins Market Sales By Geography (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Biosimilar Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Contract Manufacturing Organization Market Sales By Geography (USD MN)
  • Contract Research Organization Market Sales By Geography (USD MN)
  • Food & Feed Industry Market Sales By Geography (USD MN)
  • Academic Research Organization Market Sales By Geography (USD MN)
  • Global Bioprocess Technology Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Bioprocess Technology Report
  • Market Research Process
  • Market Research Methodology
  • Global Bioprocess Technology Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Consumables & Accessories (Culture Media, Reagents, Others) Market Sales By Geography (USD MN)
  • Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Primary Surgical Market Sales By Geography (USD MN)
  • Antibiotics Market Sales By Geography (USD MN)
  • Recombinant Proteins Market Sales By Geography (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Biosimilar Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Contract Manufacturing Organization Market Sales By Geography (USD MN)
  • Contract Research Organization Market Sales By Geography (USD MN)
  • Food & Feed Industry Market Sales By Geography (USD MN)
  • Academic Research Organization Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11213676

Global Bioprocess Technology Market size is anticipated to grow from USD 37.63 Billion in 2024 to USD 80.78 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.86% during the forecast period of 2026 to 2033.

The bioprocess technology market is experiencing significant growth, driven by the increasing demand for biopharmaceuticals and the need for efficient production processes. Bioprocess technology encompasses a range of techniques used to develop and manufacture biological products, including vaccines, monoclonal antibodies, and recombinant proteins. As the global biopharmaceutical industry continues to expand, the demand for advanced bioprocessing solutions that enhance productivity and reduce costs is on the rise. Companies are increasingly investing in bioprocess technology to streamline their manufacturing operations and improve product quality, positioning this market for robust expansion.

Moreover, advancements in bioprocess technology are driving innovation within the market. The development of continuous manufacturing processes, single-use technologies, and automation solutions is transforming the way biopharmaceuticals are produced. These innovations not only enhance efficiency but also reduce the risk of contamination and improve scalability. As the bioprocess technology market continues to evolve, ongoing research and development efforts will play a crucial role in expanding the range of solutions available to meet the diverse needs of the biopharmaceutical industry.

Additionally, the growing emphasis on personalized medicine and targeted therapies is shaping the bioprocess technology landscape. As healthcare providers increasingly seek to tailor treatments to individual patients, the demand for flexible and adaptable bioprocessing solutions is likely to rise. This trend is particularly relevant in the context of cell and gene therapies, where the production of customized biological products requires advanced bioprocessing techniques. As the bioprocess technology market continues to grow, the convergence of technological advancements, regulatory compliance, and the push for personalized medicine will play a pivotal role in shaping its future trajectory, ensuring that biopharmaceutical companies can meet the evolving demands of the healthcare landscape.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

  • Consumables & Accessories (Culture Media, Reagents, Others)
  • Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration)

By Application

  • Primary Surgical
  • Antibiotics
  • Recombinant Proteins
  • Monoclonal Antibodies
  • Biosimilar

By End-user

  • Biopharmaceutical Companies
  • Contract Manufacturing Organization
  • Contract Research Organization
  • Food & Feed Industry
  • Academic Research Organization
  • COMPANIES PROFILED
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • GE Healthcare
  • Sartorius AG
  • Becton
  • Dickinson and Company
  • Danaher Corporation
  • Eppendorf AG
  • Lonza
  • Advanced Instruments
  • Nova Biomedical
  • F. Hoffmann-La Roche Ltd.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BIOPROCESS TECHNOLOGY a€" INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOPROCESS TECHNOLOGY MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Consumables & Accessories (Culture Media, Reagents, Others) Historic and Forecast Sales By Regions
  • 5.4. Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration) Historic and Forecast Sales By Regions

6. GLOBAL BIOPROCESS TECHNOLOGY MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Primary Surgical Historic and Forecast Sales By Regions
  • 6.4. Antibiotics Historic and Forecast Sales By Regions
  • 6.5. Recombinant Proteins Historic and Forecast Sales By Regions
  • 6.6. Monoclonal Antibodies Historic and Forecast Sales By Regions
  • 6.7. Biosimilar Historic and Forecast Sales By Regions

7. GLOBAL BIOPROCESS TECHNOLOGY MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data Analysis By End-user
  • 7.3. Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 7.4. Contract Manufacturing Organization Historic and Forecast Sales By Regions
  • 7.5. Contract Research Organization Historic and Forecast Sales By Regions
  • 7.6. Food & Feed Industry Historic and Forecast Sales By Regions
  • 7.7. Academic Research Organization Historic and Forecast Sales By Regions

8. GLOBAL BIOPROCESS TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BIOPROCESS TECHNOLOGY COMPANIES

  • 9.1. Bioprocess Technology Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF BIOPROCESS TECHNOLOGY INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Thermo Fisher Scientific Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Siemens Healthineers
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. GE Healthcare
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Sartorius AG
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Becton
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Dickinson And Company
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Danaher Corporation
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Eppendorf AG
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Lonza
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Advanced Instruments
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Nova Biomedical
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. F. Hoffmann-La Roche Ltd
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies